Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply

Lancet Oncol. 2021 Jun;22(6):e222. doi: 10.1016/S1470-2045(21)00291-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chemoradiotherapy / adverse effects
  • Humans
  • Lung Neoplasms* / drug therapy
  • Small Cell Lung Carcinoma* / drug therapy